Literature DB >> 6807529

Colon-specific antigen-p (CSAp). II. Further characterization in colorectal and pancreatic cancer.

D Shochat, K D Pant, D M Goldenberg.   

Abstract

The physicochemical and immunological characteristics of colon-specific antigen-p (CSAp) in plasma and in colorectal and pancreatic tumors were investigated. CSAp in the plasma of a rectal cancer patient and in a colonic carcinoma xenografted in hamsters (GW-39 tumor) appeared to have similar chromatographic properties, being of a molecular size of 4 million or more. The activities of CSAp in both plasma and tumor were similarly destroyed by treatment with a thiol reagent. Finally, identical immunological reactions in radioimmunoassay and gel diffusion tests were obtained between the CSAp's in patient plasma and in GW-39 tumor tissue. Also CSAp in human pancreatic cancers xenografted in nude mice showed a precipitin line of complete identity with CSAp extracted from GW-39 human colonic carcinoma transplants. Thus, the CSAp's found in colorectal cancer patient plasma, in colonic carcinoma, and in pancreatic cancer tissues appear to be immunologically identical.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807529     DOI: 10.1002/1097-0142(19820901)50:5<927::aid-cncr2820500521>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Immunochemical characterization of mucins. Polypeptide (M1) and polysaccharide (A and Leb) antigens.

Authors:  J Bara; R Gautier; J Le Pendu; R Oriol
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

2.  Biochemical characterization of a rat oncofetal colonic antigen defined by a monoclonal antibody raised against gastric surface epithelium.

Authors:  C Decaens; J Nardelli; J Bara; P Burtin
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

Review 3.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.